Related Experiment Videos
Cranial repair using BMP-2 gene engineered bone marrow stromal cells.
Sophia Chia-Ning Chang1, Huoli Chuang, Yu-Ray Chen
1Tissue Engineering Center, Department of Plastic Surgery, Chang-Gung Memorial Hospital, Chang Gung Institute of Technology, Taipei, Taiwan. schang@adm.cgmh.org.tw
The Journal of Surgical Research
|May 6, 2004
Summary
Tissue engineered bone using mesenchymal stem cells (MSCs) and BMP-2 gene therapy effectively repaired large cranial defects in rabbits. This approach offers a promising alternative to traditional bone grafts for craniofacial reconstruction.
Area of Science:
- Regenerative Medicine
- Biomaterials Science
- Gene Therapy
Background:
- Traditional bone grafts have limitations for cranial defect repair.
- Tissue-engineered bone presents a promising alternative for craniofacial reconstruction.
Purpose of the Study:
- To evaluate the efficacy of tissue-engineered bone using mesenchymal stromal cells (MSCs) genetically modified with BMP-2 for repairing critical-size cranial defects in rabbits.
Main Methods:
- Rabbit MSCs were cultured, infected with adenovirus-BMP-2, and combined with alginate to form a construct.
- Critical-size cranial defects were created in rabbits, and defects were filled with either MSC/BMP-2 constructs or control constructs.
- Histological and 3D CT imaging analyses were performed at 1 week, 6 weeks, and 3 months post-implantation.
Main Results:
- Near-complete repair of cranial defects was observed with the MSC/alginate construct.
- Significant bone formation was evident by 3D CT imaging at 3 months (p < 0.001), but not at 6 weeks.
- Histological staining (H&E, von Kossa) indicated enhanced bone regeneration at the defect site.
Conclusions:
- Tissue-engineered bone, combining stem cells and gene medicine, can achieve near-complete repair of large cranial defects.
- Novel polymers and stem cell-based gene therapy are crucial for successful craniofacial bone regeneration.